- NeuroQuant® Brain Tumor
FDA-cleared software for advanced brain tumor analyses
Powered by Al, NeuroQuant® Brain Tumor assists radiologists, oncologists, neurosurgeons, and the Tumor Board by providing objective quantification and analysis of tumor changes over time
Comprehensive Brain Tumor Analysis
- Glioma Segmentation
Advanced classification and segmentation of both high-grade and low-grade gliomas in pre- and postoperative studies. Our AI analyzes regions of interest including the necrotic core, enhancing tumor tissue, surrounding FLAIR hyperintensity, and resection cavity.
Required sequences: T1 pre, T1 post, T2, and T2 FLAIR
- Metastasis Segmentation
Designed for both single- and multi-timepoint studies, this module classifies and tracks brain metastases over time. It analyzes new, enlarging, shrinking, stable, and resolved lesions with comprehensive output including lesion count, individual and total volumetrics, and precise lesion location.
Required sequences: T1 pre and T1 post
- Meningioma Segmentation
Supports both single- and multi-timepoint analysis of meningiomas. The system segments the necrotic core and enhancing tissue, providing detailed volumetric data for current, prior, and interval change analysis.
Required sequences: T1 pre and T1 post
Objective Tumor Insights Made Simple
Segmentation & Volumetrics Report
Detailed volumes of tumor regions are provided in comprehensive reports and automatically routed to PACS for seamless integration into your workflow.
Longitudinal Analysis
Prior studies of the same patients are automatically included on reports for precise volumetric comparison over time, enabling better treatment monitoring.
Tumor Segmentation Color Overlay Series
Slice-by-slice tumor segmentations are routed to PACS with tumor regions of interest color coded for easy viewing and interpretation.
RT STRUCT
Advanced contour generation that can be manipulated for treatment planning, surgical planning, and radiation oncology applications.
NeuroQuant® Brain Tumor Benefits
Enhanced Objectivity & Reproducibility
Quantitative brain tumor volumetrics provide more objectivity and are more reproducible than 2D visual analyses ¹
¹ Blomstergen et al., (2018, July)
Time-Series Analysis
Displays time-series data for tumor volumes across multiple scans, allowing for better comparison and treatment planning
Comprehensive Tumor Coverage
Supports the analysis of gliomas, metastases, and meningiomas, offering broader clinical utility than solutions limited to one tumor type
NeuroQuant® Brain Tumor Reports
Comprehensive segmentation and volumetrics reporting, automatically routed to PACS.
Glioma Quantification Report: High-Grade
Supports longitudinal assessment of surgical outcomes with volumetric comparison of residual tumor across timepoints. 3D visualization helps inform follow-up care and treatment planning.
Glioma Quantification Report: Low-Grade
NeuroQuant Brain Tumor identifies and quantifies whole lesion volume, whether enhancing or non-enhancing, to support consistent tracking of both low- and high-grade gliomas across timepoints.
Brain Metastasis Quantification Report
The NeuroQuant Brain Tumor Metastasis report detects, quantifies, and monitors up to 50 lesions per scan—highlighting new, resolved, shrinking, or enlarging tumors to streamline interpretation and support longitudinal decision-making.
Meningoima Quantification Report
The NeuroQuant Brain Tumor Meningioma report offers precise measurement and segmentation of enhancing tumor and necrotic core volumes, enabling confident assessment of tumor progression or response to treatment across multiple timepoints.
Understanding CPT Codes 0865T & 0866T
As of January 1, 2024, new Category III CPT codes (0865T, 0866T) are active for AI-assisted quantitative brain MRI analysis. These codes apply to a variety of vendor solutions, including Cortechs.ai, and serve as an essential step toward achieving permanent reimbursement.
